Tag: ACS
TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI
A prespecified analys...
Alirocumab receives EC approval in established atherosclerotic cardiovascular disease
The European Commission (...
Age is a strong predictor of spontaneous myocardial infarction in medically managed patients
Renato D Lopes (Divis...
